juan iovanna | Personalized Medicine | Best Researcher Award

Published on by Top Pharmaceutical

juan iovanna | Personalized Medicine | Best Researcher Award

Prof. Dr. juan iovanna, INSERM, France

Prof. Dr. Juan Iovanna è un medico e ricercatore internazionale esperto in oncologia, specializzato nello studio del carcinoma pancreatico. Laureato e dottorato all’Università di Buenos Aires, lavora in Francia dal 1991 presso l’INSERM, dove ha raggiunto il grado di Direttore di Ricerca di Classe Eccezionale. Co-dirige il gruppo “Biologia del cancro pancreatico” al CRCM di Marsiglia e presiede il Programma G7 Cancer. Fondatore di tre start-up biotecnologiche, ha pubblicato 472 articoli con oltre 43.500 citazioni 📚. La sua missione è migliorare la prognosi del tumore pancreatico attraverso ricerca e innovazione terapeutica.

Publication Profile

orcid

Education

Prof. Dr. Juan Iovanna began his academic journey with a degree in Medicine from the University of Buenos Aires, Argentina, in 1982. Driven by a passion for biomedical research, he pursued a Ph.D. in Biomedical Sciences at the same university, which he completed in 1986. 🧬 His doctoral thesis, titled “Meccanismi di regolazione della sintesi proteica in modelli cellulari di stress,” focused on the mechanisms regulating protein synthesis in cellular stress models. 🧪 This foundational work laid the groundwork for his future contributions to medical science and molecular biology.

Experience

🔬 Prof. Dr. Juan Iovanna has built an illustrious career in cancer research. In 1991, he began as a researcher at INSERM in France and was promoted to Research Director in 1993 and again in 1998. 🚀 In 2011, he achieved the prestigious title of Directeur de Recherche de Classe Exceptionnelle (DRCE). From 2011 to 2023, he served as Vice-Director of the Marseille Cancer Research Center (CRCM) and led its Translational Medicine Department. 🧫 He also directed the “Pancreatic Cancer Biology” group from 1999 to 2023. Since 2024, he co-directs this group with Dr. Nelson Dusetti and serves as Emeritus Research Director.

Distinctions and Awards

Prof. Dr. Juan Iovanna has received numerous prestigious awards and honors throughout his career. In 2017, he was awarded the Jean Valade Prize by the Fondation de France for his outstanding contributions to biomedical research. 🌍 In 2018, he received the RAICES Award from Argentina’s Ministry of Science, Technology, and Innovation. 🇫🇷 In 2021, the French Senate honored him with a commemorative medal. In 2023, he was named Honorary Professor at the National University Arturo Jauretche (UNAJ), and in 2024, he was recognized as a Distinguished and Honorary Member of the University of Buenos Aires.

Research Focus

Prof. Dr. Juan Iovanna’s research is centered on precision oncology, with a primary focus on pancreatic ductal adenocarcinoma (PDAC). His work integrates transcriptomics, drug resistance mechanisms, redox metabolism, and multi-omics modeling to uncover novel therapeutic vulnerabilities and biomarkers. He contributes to the development of RNA signatures (like GemPred) to predict chemotherapy response, and investigates KRAS inhibition and therapy-induced senescence as pathways to reverse drug resistance. His translational studies aim to optimize personalized treatment strategies for pancreatic cancer patients, bridging molecular insights with clinical application.

Publication Top Notes

KRAS inhibition reverses chemotherapy resistance promoted by therapy-induced senescence-like in pancreatic ductal adenocarcinoma

The PancreasView gemcitabine transcriptomic signature predicts response to gemcitabine in patients with resected pancreatic ductal adenocarcinoma

Adaptation of redox metabolism in drug-tolerant persister cells is a vulnerability to prevent relapse in pancreatic cancer

Reply to the Letter to the Editor regarding ‘Chi-squared and P-values vs. machine learning feature selection by Y. Takefuji’

Reply to the Letter to the Editor ‘AI-assisted personalized adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma’ by Y. Shimazu

Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical Trial
Inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity
Limitation and challenges in using pancreatic cancer‐derived organoids as a preclinical tool

Multi-omics data integration and modeling unravels new mechanisms for pancreatic cancer and improves prognostic prediction

Mario Leporace | Personalized Medicine | Best Innovation Award

Published on by Top Pharmaceutical

Mario Leporace | Personalized Medicine | Best Innovation Award

Prof. Dr. Mario Leporace, Hospital and University, Italy

Prof. Dr. Mario Leporace is a distinguished Clinical Radiologist at the Department of Nuclear Medicine and Theragnostics, “Mariano Santo” Hospital, Cosenza, Italy. With expertise in oncologic imaging, hybrid and molecular imaging, and cardiovascular radiology, he is renowned for his advanced diagnostic work using X-ray, CT, MRI, PET/CT, and SPECT/CT. He holds a Master’s in Interventional Oncology and has contributed to over 15 peer-reviewed publications. His professional journey spans top institutions in Rome and Cosenza, marking a career dedicated to innovation in radiology and nuclear medicine.

Publication Profile

Scopus

Education

Prof. Dr. Mario Leporace 🎓 is a distinguished expert in interventional oncology and radiology. In 2022, he earned a Master’s Degree in Interventional Oncology from Fondazione Policlinico Universitario A. Gemelli IRCCS in Rome, with a thesis on thermal ablation of bone metastases 🔥🦴. From 2001 to 2005, he completed his post-graduate certification in Radiology at the University of Rome “Tor Vergata” 🏥, graduating cum laude with a thesis on hybrid imaging 🧠📸. He also obtained his Degree in Medicine and Surgery from the same university (1995–2001), graduating with top honors and a thesis in vascular imaging 🫀🧬.

Experience

Prof. Dr. Mario Leporace 🩺 has an extensive career in radiology and nuclear medicine, showcasing over two decades of dedicated medical service. Since October 2017, he has been serving in the Department of Nuclear Medicine and Theragnostics at “Mariano Santo” Hospital in Cosenza, Italy ⚛️🏥. From May 2016 to September 2017, he worked at the Department of Radiology, “Annunziata” Hospital 🏨. Earlier, from March 2006 to April 2016, he contributed to the European Hospital in Rome, and concurrently, from November 2005 to April 2016, served at the Aurelia Hospital in Rome 🏛️🔬, strengthening his clinical expertise across institutions.

Research Focus

Prof. Dr. Mario Leporace focuses his research on Thermal Ablation with Magnetic Resonance-guided Focused Ultrasound Surgery (MRgFUS) 🔬🧠. His work bridges medical physics and oncological applications, exploring non-invasive treatments that use focused ultrasound energy to thermally ablate tumors with MRI precision guidance 🎯. This technique offers cutting-edge therapeutic possibilities in fields such as oncology, neurology, and women’s health 🧬💡. Prof. Leporace’s contributions advance both the clinical outcomes and technological innovation of MRgFUS, making him a key figure in image-guided therapy, minimally invasive surgery, and cancer treatment research .

Publication Top Notes

The Thermal Ablation with MRgFUS: From Physics to Oncological Applications

Nigatu Gebrehiwot | Precision Medicine | Best Researcher Award

Published on by Top Pharmaceutical

Nigatu Gebrehiwot | Precision Medicine | Best Researcher Award

Dr. Nigatu Gebrehiwot, Zhengzhou University, China

Dr. Nigatu Gebrehiwot is a dedicated PhD candidate in Pharmacology at Zhengzhou University, China, specializing in drug safety evaluation. He holds a Master’s in Clinical and Administrative Pharmacy from Xi’an Jiaotong University and a Bachelor of Pharmacy from Mekelle University, where he was recognized as an outstanding student. A published researcher and global presenter, Dr. Gebrehiwot has earned accolades including recognition at ISPOR in Barcelona. He is actively involved in multiple international scientific societies and brings strong expertise in pharmacotherapy, academic writing, and collaborative healthcare research. His work explores methionine metabolism and innovative therapeutic strategies.

Publication Profile

Orcid

Education

Dr. Nigatu Gebrehiwot holds a Master’s degree in Clinical and Administrative Pharmacy from Xi’an Jiaotong University, where his research earned an award at the 21st European Congress ISPOR Health Outcome Research Conference in Barcelona, Spain. 🏅 He also earned a Bachelor’s degree in Pharmacy from Mekelle University, where he was recognized as the most outstanding student in his class. 🎓 His academic achievements reflect his dedication to advancing the field of pharmacy, blending clinical expertise with research excellence. Dr. Gebrehiwot’s work continues to impact the healthcare landscape positively.

Experience

Dr. Nigatu Gebrehiwot is currently a Ph.D. candidate in Pharmacology at the Center for Drug Safety Evaluation and Research, Zhengzhou University, Henan, China, since September 2022. 🎓 Prior to this, he served as the Principal Scientific Officer at the Federal Ministry of Health (FMOH) in Ethiopia from June 2020 to 2021. During his tenure, Dr. Gebrehiwot managed national disease programs and medicines, overseeing the funding and evaluation of treatment guidelines and drug therapy protocols in accordance with Ethiopian legislation and EFDA guidelines. 💊 He also led technical committees focused on antimicrobial therapy, cancer, and chronic disease management.

Awards

Dr. Nigatu Gebrehiwot received a prestigious award for his research abstract at the 21st European Congress ISPOR Health Outcome Research conference in Barcelona, Spain. 🏆 This recognition underscores the significant impact of his work in the field of pharmacology and health outcome research. 🌍 His contributions continue to advance knowledge and influence healthcare practices, making him a respected figure in his field. 💡 Dr. Gebrehiwot’s dedication to research excellence and his ability to address critical health issues have earned him well-deserved acknowledgment on an international stage.

Research Focus

Dr. Nigatu Tadesse’s research primarily focuses on molecular alterations in disease processes, with an emphasis on metabolic pathways and their potential as diagnostic and therapeutic targets. His work on gastric intestinal metaplasia and methionine metabolism sheds light on novel approaches to diagnosis and treatment. Additionally, Dr. Tadesse has contributed significantly to pharmacology, particularly the study of traditional medicines like Dioscorea zingiberensis, investigating its phytochemistry, clinical applications, and toxicity. His research also extends to industrial processes, such as wastewater treatment in diosgenin production. His interdisciplinary work connects biomedicine, pharmacology, and environmental science.

Publication Top Notes

Molecular Alterations in Gastric Intestinal Metaplasia Shed Light on Alteration of Methionine Metabolism: Insight into New Diagnostic and Treatment Approaches

Knowledge, attitude and antibiotic prescribing patterns of medical doctors providing free healthcare in the outpatient departments of public hospitals in Sierra Leone: A national cross-sectional study

Dioscorea zingiberensis C. H. Wright: An overview on its traditional use, phytochemistry, pharmacology, clinical applications, quality control, and toxicity

First total synthesis of a novel amide alkaloid derived from Aconitum taipeicum and its anticancer activity

Methods to treat the industrial wastewater in diosgenin enterprises produced from Diosorea zingiberensis C. H. Wright

Safety investigation on total steroid saponins extracts from Dioscorea zingiberensis C.H. Wright: Sub-acute and chronic toxicity studies on dogs

Jose M. Soriano | Precision Medicine | Best Researcher Award

Published on by Top Pharmaceutical

Jose M. Soriano | Precision Medicine | Best Researcher Award

Prof Jose M. Soriano, University of Valencia, Spain

Prof. José M. Soriano is a Full Professor at the Faculty of Pharmacy, Universitat de València, specializing in food safety, toxicology, and nutrition. He holds a Ph.D. in Food Safety and Toxicology (2001) and degrees in Pharmacy (1996) and Human Nutrition and Dietetics (2018). He has led over 50 national and international projects and published 199 journal articles. With an impressive citation index of 5,263, Prof. Soriano is also Editor-in-Chief of the Spanish Journal of Human Nutrition and Dietetics and has published 50 books. His research focuses on nutraceutics, food safety, and toxicology. 📚🍏🔬

Publication Profile

Google Scholar

Academic Background

Prof. José M. Soriano holds a doctorate in Food Safety and Toxicology, along with degrees in Pharmacy and Human Nutrition. With extensive experience in pharmacy, food science, and nutrition research, he is a Full Professor at Universitat de València. His expertise covers critical areas such as food safety, toxicology, and nutrition, where he contributes to advancing scientific understanding. Prof. Soriano’s work bridges academia and practical application, ensuring a deep impact on public health and safety. 🍏🔬📚

Research and Innovations

Prof. José M. Soriano is a distinguished researcher with extensive expertise in food safety, nutrition, and toxicology. He has led over 50 national and international projects, significantly advancing scientific understanding in these critical areas. With more than 5,200 citations and 199 publications in renowned journals, his work has made a lasting impact. Prof. Soriano’s involvement in over 20 consultancy and industry projects further highlights the practical application of his research. His contributions continue to shape the fields of food safety and toxicology, ensuring better public health and informed industry practices. 📚🔬🌍🥗🧬

Editorial and Collaborative Roles

Prof. José M. Soriano is a renowned expert in human nutrition and dietetics, currently serving as the Editor-in-Chief of the Spanish Journal of Human Nutrition and Dietetics. Through his leadership and extensive collaborations with prestigious institutions across Africa and Asia, he actively contributes to advancing research and education in the field. Prof. Soriano’s dedication to improving global health, particularly through nutrition, has earned him recognition across continents. His work plays a significant role in fostering knowledge exchange and implementing impactful solutions in diverse healthcare settings. 🌍🍏📚💡👨‍⚕️

Professional Recognition

Prof. José M. Soriano is highly esteemed within the scientific community, evident through his memberships in prestigious organizations like the Spanish Academy of Nutrition and Dietetics and the Academy of Pharmacy of the Valencian Community. His recognition in these influential bodies reflects his significant contributions to the fields of nutrition, dietetics, and pharmacy. Through his work, Prof. Soriano has earned respect and credibility, underscoring his dedication to advancing knowledge and practices in these vital areas. His ongoing involvement with these academies is a testament to his ongoing impact and influence. 👨‍⚕️📚🏅

Research Focus

Based on the provided research publications, the individual appears to focus primarily on food safety and toxicology, with a particular interest in mycotoxins and their effects on human health. Their work spans areas like the toxicity, occurrence, and detoxification of mycotoxins such as aflatoxins, zearalenone, and fumonisins. Additionally, they have explored the mechanisms of action of sphingolipids in toxicity, food contamination, and microbiological quality in food products like lettuce and milk. This researcher is also involved in studies on obesity and nutrition, highlighting their expertise in both food toxicology and clinical nutrition. 🧪🍽️🔬🦠

Publication Top Notes

Review on the toxicity, occurrence, metabolism, detoxification, regulations and intake of zearalenone: an oestrogenic mycotoxin

Mechanism of action of sphingolipids and their metabolites in the toxicity of fumonisin B1

Presence of aflatoxin M1 in pasteurized milk from Morocco

Determination of aflatoxins in peanuts by matrix solid-phase dispersion and liquid chromatography

Assessment of the microbiological quality and wash treatments of lettuce served in University restaurants

Incidence of ochratoxin A in rice and dried fruits from Rabat and Salé area, Morocco

Incidence of microbial flora in lettuce, meat and Spanish potato omelette from restaurants

 

 

Assoc Prof Dr.Mahmoud Nikseresht, Precision Medicine,Best Researcher Award-1172

Published on by Top Pharmaceutical

Assoc Prof Dr.Mahmoud Nikseresht ,Precision Medicine ,Best Researcher Award

Assoc Prof Dr.Mahmoud Nikseresht, at Ilam Branch, Islamic Azad University, Iran

Author Profile

 

Education:

  • Postdoctoral Clinical Research Fellow (2016): Institute of Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
    Project: “Detraining-induced alterations in adipokines and cardio-metabolic risk factors after nonlinear periodized resistance and aerobic interval training in obese men.”
  • Ph.D. in Exercise Physiology (2013): Central Tehran Branch, Islamic Azad University, Tehran, Iran.
    Dissertation: “Effects of nonlinear resistance and high-intensity interval aerobic training on resting levels of cytokines in obese men.”
  • Master of Science in Sport and Exercise Physiology (2006): Central Tehran Branch, Islamic Azad University, Tehran, Iran.
    Thesis: “The effects of endurance, plyometrics, and concurrent training on salivary immunoglobulins and bio-energetic characteristics in soccer players.”
  • Bachelor of Science in Physical Education and Sport Sciences (2004): Kharazmi University, Tehran, Iran.

Employment:

  • Associate Professor (2021-present): Department of Exercise Physiology, Islamic Azad University, Ilam Branch.
  • Assistant Professor (2013-2021): Department of Exercise Physiology, Islamic Azad University, Ilam Branch.
  • Instructor (2007-2013): Department of Physical Education and Sport Sciences, Islamic Azad University, Ilam Branch.

Professional Memberships:

  • Member of the European College of Sports Sciences (ECSS) (2010-present)
  • Chair of the ECSS (2018-present)

Publications and Research: Dr. Nikseresht has contributed significantly to the field of exercise physiology through his research and publications. Some of his notable works include:

  • In Progress:

    1. Assessing Physical Activity Levels Among Secondary Students in the West of Iran: A Cohort Study (2023)
    2. Heart Rate and Aerobic Endurance Performance Response during an Incremental Exercise to Exhaustion in Hookah-Smoking Soccer Players (2022)

🎓Publication Top Noted:

Paper Title :Effects of nonlinear resistance and aerobic interval training on cytokines and insulin resistance in sedentary men who are obese

  • Authors   : Mahmoud Nikseresht, Hamid Agha-Alinejad, Mohammad A Azarbayjani, Khosrow Ebrahim
  • Journal    :The Journal of Strength & Conditioning Research
  • Year         : 2014
Paper Title : Detraining-induced alterations in adipokines and cardiometabolic risk factors after nonlinear periodized resistance and aerobic interval training in obese men
    • Authors :   Mahmoud Nikseresht, Mohammad Reza Hafezi Ahmadi, Mehdi Hedayati
    • Journal   : Applied Physiology, Nutrition, and Metabolism
    • Year       : 2016
Paper Title :  Inflammatory markers and adipocytokine responses to exercise training and detraining in men who are obese
  • Authors  :  Mahmoud Nikseresht, Nourkhoda Sadeghifard, Hamid Agha-Alinejad, Khosrow Ebrahim
  • Journal    : The Journal of Strength & Conditioning Research
  • Year         :  2014
Paper Title : Comparison of serum cytokine levels in men who are obese or men who are lean: effects of nonlinear periodized resistance training and obesity
  • Authors  :  Mahmoud Nikseresht
  • Journal   : The Journal of Strength & Conditioning Research
  • Year        :   2018

Paper Title :Comparison of serum interleukin-18 and C-reactive protein levels in obese and non-obese young men: Effects of exercise training and obesity

  • Authors  :  Mahmood Nikseresht
  • Journal   : Journal of Sabzevar University of Medical Sciences
  • Year        : 2018